Obesity is a chronic disease associated with increased risk of obesity-related complications
and mortality. Our better understanding of the weight regulation mechanisms and the role of …

Obesity is a serious chronic disease and an independent risk factor for the new onset and
progression of chronic kidney disease (CKD). CKD prevalence is expected to increase, at …

A revolution in obesity treatment | Nature Medicine Skip to main content Thank you for visiting
nature.com. You are using a browser version with limited support for CSS. To obtain the best …

Currently, metabolic surgery (MS) constitutes the most effective means for durable weight
loss of clinically meaningful magnitude, type 2 diabetes remission and resolution of non …

Obesity and type 2 diabetes mellitus (T2DM) are widespread, non-communicable diseases
that are responsible for considerable levels of morbidity and mortality globally, primarily in …

Importance Among individuals with obesity, 5% or greater weight loss can improve health.
Weight management treatments (WMT) include nutrition counseling, very low-calorie meal …

Options for the treatment of type 2 diabetes mellitus (T2DM) and obesity have recently been
expanded by the results of several large clinical trials with incretin-based peptide therapies …

Obesity is the fifth leading risk factor for global deaths with numbers continuing to increase
worldwide. In the last 20 years, the emergence of pharmacological treatments for obesity …

The year 2023 brought reports of highly effective glucagon-like peptide 1 (GLP1) mono-
agonists or combinations with amylin receptor agonists. Results for monomolecular co …

Several recent advances provide multiple health benefits to individuals with type 2 diabetes
mellitus (T2DM). Pharmacological therapy is governed by person‐centered factors …